Edgewell Personal Care (EPC) Projected to Release Quarterly Earnings on Thursday

Key Points

• Edgewell Personal Care is expected to report Q4 2026 results before markets open on November 12; analysts forecast $0.77 earnings per share and $479.88 million in revenue.
• In its most recent quarter, Edgewell beat EPS estimates ($0.72 versus $0.64) but missed revenue expectations, with sales down 9.1% year over year.
• Analysts’ average rating is Hold, with an average price target of $31.50; shares recently rose 6.0%.

Edgewell Personal Care (NYSE:EPC - Get Free Report) is expected to release its Q4 2026 results before the market opens on Thursday, November 12th. Analysts expect Edgewell Personal Care to announce earnings of $0.7710 per share and revenue of $479.88 million for the quarter. Investors may visit the company's upcoming Q4 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 12, 2026 at 8:00 AM ET.

Edgewell Personal Care (NYSE:EPC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.72 EPS for the quarter, topping analysts' consensus estimates of $0.64 by $0.08. Edgewell Personal Care had a positive return on equity of 5.76% and a negative net margin of 4.55%. The business had revenue of $570.10 million during the quarter, compared to analysts' expectations of $574.87 million. During the same quarter in the prior year, the business posted $1.04 earnings per share. The business's quarterly revenue was down 9.1% on a year-over-year basis. On average, analysts expect Edgewell Personal Care to post $1.94 EPS for the current fiscal year and $2.03 EPS for the next fiscal year.

Edgewell Personal Care Stock Up 6.0%

NYSE EPC opened at $29.62 on Thursday. Edgewell Personal Care has a 52 week low of $15.73 and a 52 week high of $30.03. The company has a quick ratio of 1.12, a current ratio of 1.84 and a debt-to-equity ratio of 0.85. The company has a market capitalization of $1.36 billion, a P/E ratio of -14.81 and a beta of 0.36. The stock's 50-day moving average price is $27.80 and its 200-day moving average price is $24.03.

Analysts Set New Price Targets

A number of research analysts recently issued reports on EPC shares. Barclays boosted their price objective on Edgewell Personal Care from $28.00 to $29.00 and gave the company an "equal weight" rating in a research note on Friday, August 7th. Weiss Ratings raised shares of Edgewell Personal Care from a "sell (d)" rating to a "sell (d+)" rating in a report on Tuesday, August 25th. Royal Bank Of Canada upped their price target on shares of Edgewell Personal Care from $26.00 to $35.00 and gave the stock an "outperform" rating in a research report on Thursday, August 6th. UBS Group reiterated a "neutral" rating and issued a $30.00 price target on shares of Edgewell Personal Care in a research report on Thursday, October 15th. Finally, Wells Fargo & Company reduced their price objective on shares of Edgewell Personal Care from $32.00 to $30.00 and set an "overweight" rating for the company in a research note on Monday, October 5th. Three investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $31.50.

About Edgewell Personal Care

Edgewell Personal Care Company NYSE: EPC is a global consumer products company focused on personal care products. Its portfolio includes shaving, sun care, skin care and feminine care products sold under brands such as Schick, Wilkinson Sword, Edge, Skintimate, Billie, Banana Boat, Hawaiian Tropic, Bulldog, Jack Black and Playtex.

The company's shaving business offers razors, blades, shaving creams and gels for men and women. Its sun and skin care operations provide sunscreen, after-sun products and related personal care items, while its feminine care portfolio includes tampons and other menstrual care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.